Literature DB >> 6292769

GABAergic regulation of the substantia innominata-cortical cholinergic pathway.

P L Wood, J Richard.   

Abstract

Neurochemical and immunohistocytochemical studies have demonstrated a nucleus accumbens-substantia innominata GABAergic pathway. The present authors' data with muscimol given parenterally, as well as local injections into the substantia innominata, further support an inhibitory function for this pathway in the regulation of the substantia innominata-cortical cholinergic projection.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6292769     DOI： 10.1016/0028-3908(82)90108-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


  5 in total

1.  Alterations in acetylcholinesterase activity in plasma and synaptosomal fractions from C.N.S. of rats acutely intoxicated with lindane. Effect of succinylcholine.

Authors:  J M González-Rodriguez Córdoba; J M Cabanás-Espejo; M Martínez Luque-Romero; J Muñoz-Blanco
Journal:  Bull Environ Contam Toxicol       Date:  1987-10       Impact factor: 2.151

2.  Chronic infusion of GABA into the nucleus basalis magnocellularis or frontal cortex of rats: a behavioral and histological study.

Authors:  M Majchrzak; S Brailowsky; B Will
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 3.  The Insula and Taste Learning.

Authors:  Adonis Yiannakas; Kobi Rosenblum
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

4.  Diazepam antagonizes GABA- and muscimol-induced changes of acetylcholine release in slices of guinea-pig cerebral cortex.

Authors:  S Tanganelli; C Bianchi; L Beani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

5.  Opposing Roles of Cholinergic and GABAergic Activity in the Insular Cortex and Nucleus Basalis Magnocellularis during Novel Recognition and Familiar Taste Memory Retrieval.

Authors:  Gabriela Rodríguez-García; María Isabel Miranda
Journal:  J Neurosci       Date:  2016-02-10       Impact factor: 6.167
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.